GRN and frontotemporal dementia: Clinically, the presence of WMH is an important sign of a potential GRN mutation in a patient with familial FTD, whilst from a clinical trial point of view, it may be that measurement of WMH load will be a useful biomarker, particularly in trials targeting anti-inflammatory measures.